BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35327654)

  • 1. The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
    Malagraba G; Yarmohammadi M; Javed A; Barceló C; Rubio-Tomás T
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.
    Kim HM; Liu Z
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
    Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
    Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mammalian flavin-dependent histone demethylase.
    Karytinos A; Forneris F; Profumo A; Ciossani G; Battaglioli E; Binda C; Mattevi A
    J Biol Chem; 2009 Jun; 284(26):17775-82. PubMed ID: 19407342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Catalytic-Dependent and -Independent Roles of Lsd1 and Lsd2 Lysine Demethylases in Heterochromatin Formation in
    Marayati BF; Tucker JF; Cerda DA; Hou TC; Chen R; Sugiyama T; Pease JB; Zhang K
    Cells; 2020 Apr; 9(4):. PubMed ID: 32295063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NPAC-LSD2 complex in nucleosome demethylation.
    Caroli J; Mattevi A
    Enzymes; 2023; 53():97-111. PubMed ID: 37748839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex.
    Marabelli C; Marrocco B; Pilotto S; Chittori S; Picaud S; Marchese S; Ciossani G; Forneris F; Filippakopoulos P; Schoehn G; Rhodes D; Subramaniam S; Mattevi A
    Cell Rep; 2019 Apr; 27(2):387-399.e7. PubMed ID: 30970244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between histone demethylase LSD family and development and prognosis of gastric cancer.
    Dong L; Zhu J; Deng A; Wei J; Li J; Mao X; Jia Z
    Front Immunol; 2023; 14():1170773. PubMed ID: 37207209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.
    Fang R; Barbera AJ; Xu Y; Rutenberg M; Leonor T; Bi Q; Lan F; Mei P; Yuan GC; Lian C; Peng J; Cheng D; Sui G; Kaiser UB; Shi Y; Shi YG
    Mol Cell; 2010 Jul; 39(2):222-33. PubMed ID: 20670891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.
    Niwa H; Umehara T
    Epigenetics; 2017 May; 12(5):340-352. PubMed ID: 28277979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
    Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
    Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
    Hino S; Kohrogi K; Nakao M
    Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b.
    Zhang Q; Qi S; Xu M; Yu L; Tao Y; Deng Z; Wu W; Li J; Chen Z; Wong J
    Cell Res; 2013 Feb; 23(2):225-41. PubMed ID: 23266887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational modifications of lysine-specific demethylase 1.
    Kim D; Nam HJ; Baek SH
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194968. PubMed ID: 37572976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into histone lysine demethylation.
    Hou H; Yu H
    Curr Opin Struct Biol; 2010 Dec; 20(6):739-48. PubMed ID: 20970991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.
    Zhang L; Chen Y; Li Z; Lin C; Zhang T; Wang G
    Drug Discov Today; 2023 May; 28(5):103519. PubMed ID: 36754142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.